Linked Life Data

3914701

Source:http://linkedlifedata.com/resource/pubmed/id/3914701

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Suppl 1
pubmed:dateCreated
1986-6-9
pubmed:abstractText
Recommended dosages of nonsteroidal anti-inflammatory drugs have increased considerably since their introduction. The maximum recommended dosage for ibuprofen, a widely prescribed drug for the treatment of rheumatoid arthritis, has increased from 400 mg three or four times a day (at the time of its introduction) to 2,400 mg per day at present. Piroxicam at 20 mg per day was compared with ibuprofen at 2,400 mg per day in 20 patients with rheumatoid arthritis. Both drugs were found to be effective, with similar side-effect profiles.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0049-0172
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11-3
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
A double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial